2024中国类风湿关节炎诊疗指南

2024 Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis

类风湿关节炎(RA)是一种以侵蚀性关节炎为主要临床特征的自身免疫病,是我国人群致残的重要原因。制订和更新符合国际指南制订标准又贴近我国临床实践的RA诊疗指南具有重要意义。由国家皮肤与免疫疾病临床医学研究中心组织发起,联合中国医师协会风湿免疫专科医师分会、中国康复医学会风湿免疫病康复专业委员会、中国研究型医院学会风湿免疫专业委员会和北京整合医学学会风湿免疫分会,采用推荐意见分级评估、制订及评价(GRADE)分级体系和国际实践指南报告标准(RIGHT),对《2018中国类风湿关节炎诊疗指南》进行更新,就我国风湿免疫科医师关注的10个临床问题,给出了循证推荐,形成了本指南,旨在整体提高我国RA的诊治水平和治疗规范度,提高患者的生活质量,改善患者预后。

Rheumatoid arthritis(RA)is an autoimmune disease characterized by erosive arthritis,which is an important cause of disability in Chinese population.It is of great significance to formulate and update RA diagnosis and treatment guidelines that meet the standards of international guidelines and clinical practice in China.The update of the Chinese guidelines for the diagnosis and treatment of RA was initiated by National Clinical Research Center for Dermatologic and Immunologic Diseases,jointly with the Chinese Association of Rheumatology and Immunology Physicians,the Rheumatology and Immunology Professional Committee of Chinese Rehabilitation Medical Association,the Rheumatology and Immunology Professional Committee of Chinese Research Hospital Association,and the Rheumatology and Immunology Branch of Beijing Association of Holistic Integrative Medicine.The Grading of Recommendations Assessment,Development and Evaluation(GRADE)approach and the Reporting Items for Practice Guidelines in Healthcare(RIGHT)checklist were followed to update the guidelines.The guidelines provide evidence-based recommendations on 10 clinical issues which were concerned by Chinese rheumatologists.The aim is to improve the level of diagnosis and standard treatment of RA in China,and to improve the quality of life and prognosis of patients.